References
- WGstoettner, JKiefer, WDBaumgartner, SPok, SPeters, OAdunka. Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol 2004;124:348–52.
- SUsami, HMoteki, KTsukada, MMiyagawa, SYNishio, YTakumi, et al. Hearing preservation and clinical outcome of 32 consecutive electric acoustic stimulation (EAS) surgeries. Acta Otolaryngol 2014;134:717–27.
- SHelbig, CSettevendemie, MMack, UBaumann, MHelbig, TStover. Evaluation of an electrode prototype for atraumatic cochlear implantation in hearing preservation candidates: preliminary results from a temporal bone study. Otol Neurotol 2011;32:419–23.
- WKGstoettner, SHelbig, NMaier, JKiefer, ARadeloff, OFAdunka. Ipsilateral electric acoustic stimulation of the auditory system: results of long-term hearing preservation. Audiol Neurootol 2006;11:49–56.
- KNHoang, CTDinh, EBas, SChen, AAEshraghi, TRVan De Water. Dexamethasone treatment of naive organ of Corti explants alters the expression pattern of apoptosis-related genes. Brain Res 2009;1301:1–8.
- DCope, RBova. Steroids in otolaryngology. Laryngoscope 2008;118:1556–60.
- JKiefer, WGstoettner, WBaumgartner, SMPok, JTillein, QYe, et al. Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004;124:272–80.
- PABird, DPMurray, MZhang, EJBegg. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otol Neurotol 2011;32:933–6.
- LSParnes, AHSun, DJFreeman. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1–17.
- FPiu, XWang, RFernandez, LDellamary, AHarrop, QYe, et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol Neurotol 2011;32:171–9.
- CHoneder, EEngleder, HSchöpper, FGabor, GReznicek, JWagenblast, et al. Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses. Audiol Neurootol 2014;19:193–202.
- AChang, HEastwood, DSly, DJames, RRichardson, SO’Leary. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res 2009;255:67–72.
- EEngleder, CHoneder, JKlobasa, MWirth, CArnoldner, FGabor. Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear. Int J Pharm 2014;471:297–302.
- HPlenkJr. The microscopic evaluation of hard tissue implants. In DFWilliams, editor. Techniques of biocompatibility testing. Volume I. Boca Raton, FL: CRC Press. 1986.
- SBraun, QYe, ARadeloff, JKiefer, WGstoettner, JTillein. Protection of inner ear function after cochlear implantation: compound action potential measurements after local application of glucocorticoids in the guinea pig cochlea. ORL J Otorhinolaryngol Relat Spec 2011;73:219–28.
- DPJames, HEastwood, RTRichardson, SJO’Leary. Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiol Neurootol 2008;13:86–96.
- BChoudhury, OFAdunka, OAwan, JMPike, CABuchman, DCFitzpatrick. Electrophysiologic consequences of flexible electrode insertions in gerbils with noise-induced hearing loss. Otol Neurotol 2014;35:519–25.
- SJO’Leary, PMonksfield, GKel, TConnolly, MASouter, AChang, et al. Relations between cochlear histopathology and hearing loss in experimental cochlear implantation. Hear Res 2013;298:27–35.
- ABurghard, TLenarz, AKral, GPaasche. Insertion site and sealing technique affect residual hearing and tissue formation after cochlear implantation. Hear Res 2014;312:21–7.
- SKPlontke, TBiegner, BKammerer, UDelabar, ANSalt. Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol 2008;29:401–6.